Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ibuprofen for Post-operative Pain in Inguinal Hernia Repair
NCT02929589Phase 3Terminated
- Sponsor
- Mike O'Callaghan Federal Medical Center
- Start
- Jul 2018
- Primary completion
- Aug 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of ibuprofen in postoperative pain (4 arms), sponsored by Mike O'Callaghan Federal Medical Center. Primary endpoint: Total Milligram Morphine Equivalent Units at 60 days. Started Jul 2018; status: terminated.
02
Drugs
ibuprofen
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT02929589.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02929589.